These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
527 related articles for article (PubMed ID: 15298956)
1. Benzo(a)pyrene diolepoxide (BPDE)-DNA adduct levels in leukocytes of smokers in relation to polymorphism of CYP1A1, GSTM1, GSTP1, GSTT1, and mEH. Lodovici M; Luceri C; Guglielmi F; Bacci C; Akpan V; Fonnesu ML; Boddi V; Dolara P Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1342-8. PubMed ID: 15298956 [TBL] [Abstract][Full Text] [Related]
2. High benzo[a]pyrene diol-epoxide DNA adduct levels in lung and blood cells from individuals with combined CYP1A1 MspI/Msp-GSTM1*0/*0 genotypes. Rojas M; Alexandrov K; Cascorbi I; Brockmöller J; Likhachev A; Pozharisski K; Bouvier G; Auburtin G; Mayer L; Kopp-Schneider A; Roots I; Bartsch H Pharmacogenetics; 1998 Apr; 8(2):109-18. PubMed ID: 10022748 [TBL] [Abstract][Full Text] [Related]
3. Impact of inherited polymorphisms in glutathione S-transferase M1, microsomal epoxide hydrolase, cytochrome P450 enzymes on DNA, and blood protein adducts of benzo(a)pyrene-diolepoxide. Pastorelli R; Guanci M; Cerri A; Negri E; La Vecchia C; Fumagalli F; Mezzetti M; Cappelli R; Panigalli T; Fanelli R; Airoldi L Cancer Epidemiol Biomarkers Prev; 1998 Aug; 7(8):703-9. PubMed ID: 9718223 [TBL] [Abstract][Full Text] [Related]
4. Modulation of benzo[a]pyrene diolepoxide-DNA adduct levels in human white blood cells by CYP1A1, GSTM1 and GSTT1 polymorphism. Rojas M; Cascorbi I; Alexandrov K; Kriek E; Auburtin G; Mayer L; Kopp-Schneider A; Roots I; Bartsch H Carcinogenesis; 2000 Jan; 21(1):35-41. PubMed ID: 10607731 [TBL] [Abstract][Full Text] [Related]
5. GSTM1 null genotype as a risk factor for anti-BPDE-DNA adduct formation in mononuclear white blood cells of coke-oven workers. Pavanello S; Siwinska E; Mielzynska D; Clonfero E Mutat Res; 2004 Mar; 558(1-2):53-62. PubMed ID: 15036119 [TBL] [Abstract][Full Text] [Related]
6. [Effects of CYP1A1 and GSTM1 gene polymorphisms and BPDE-DNA adducts on lung cancer]. Chen CM; Jin YT; Xu HY; Zhang CY; Zhang H; Zhang WM; Tan C; Sun XY Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Feb; 29(1):23-7. PubMed ID: 22311486 [TBL] [Abstract][Full Text] [Related]
7. Benzo(a)pyrene diolepoxide adducts to albumin in workers exposed to polycyclic aromatic hydrocarbons: association with specific CYP1A1, GSTM1, GSTP1 and EHPX genotypes. Pastorelli R; Cerri A; Rozio M; Dell'Omo M; Muzi G; Abbritti G; Fanelli R; Airoldi L Biomarkers; 2001; 6(5):357-74. PubMed ID: 23889309 [TBL] [Abstract][Full Text] [Related]
8. Induction of CYP1A1 and CYP1B1 and formation of carcinogen-DNA adducts in normal human mammary epithelial cells treated with benzo[a]pyrene. Keshava C; Divi RL; Whipkey DL; Frye BL; McCanlies E; Kuo M; Poirier MC; Weston A Cancer Lett; 2005 Apr; 221(2):213-24. PubMed ID: 15808407 [TBL] [Abstract][Full Text] [Related]
9. Expression of human glutathione S-transferase P1 confers resistance to benzo[a]pyrene or benzo[a]pyrene-7,8-dihydrodiol mutagenesis, macromolecular alkylation and formation of stable N2-Gua-BPDE adducts in stably transfected V79MZ cells co-expressing hCYP1A1. Kushman ME; Kabler SL; Fleming MH; Ravoori S; Gupta RC; Doehmer J; Morrow CS; Townsend AJ Carcinogenesis; 2007 Jan; 28(1):207-14. PubMed ID: 16885195 [TBL] [Abstract][Full Text] [Related]
10. BPDE-DNA adduct formation and alterations of mRNA, protein, and DNA methylation of CYP1A1, GSTP1, and GSTM1 induced by benzo[a]pyrene and the intervention of aspirin in mice. Liu A; Li X; Zhou L; Yan X; Xia N; Song Z; Cao J; Hao Z; Zhang Z; Liang R; Zhang H Environ Sci Pollut Res Int; 2023 Oct; 30(48):106549-106561. PubMed ID: 37730975 [TBL] [Abstract][Full Text] [Related]
11. [Biomarkers of gentotoxic risk and metabolic polymorphism]. Pavanello S; Clonfero E Med Lav; 2000; 91(5):431-69. PubMed ID: 11189784 [TBL] [Abstract][Full Text] [Related]
13. In vitro benzo[a]pyrene diol epoxide-induced DNA adducts and risk of squamous cell carcinoma of head and neck. Li D; Wang LE; Chang P; El-Naggar AK; Sturgis EM; Wei Q Cancer Res; 2007 Jun; 67(12):5628-34. PubMed ID: 17575128 [TBL] [Abstract][Full Text] [Related]
14. GSTM1, GSTT1 and CYP1A1 detoxification gene polymorphisms and susceptibility to smoking-related coronary artery disease: a case-only study. Manfredi S; Federici C; Picano E; Botto N; Rizza A; Andreassi MG Mutat Res; 2007 Aug; 621(1-2):106-12. PubMed ID: 17408703 [TBL] [Abstract][Full Text] [Related]
15. CYP1A1 and GSTM1 genotypes affect benzo[a]pyrene DNA adducts in smokers' lung: comparison with aromatic/hydrophobic adduct formation. Alexandrov K; Cascorbi I; Rojas M; Bouvier G; Kriek E; Bartsch H Carcinogenesis; 2002 Dec; 23(12):1969-77. PubMed ID: 12507920 [TBL] [Abstract][Full Text] [Related]
16. An association between BPDE-like DNA adduct levels and CYP1A1 and GSTM1 polymorphisma in pterygium. Tung JN; Wu HH; Chiang CC; Tsai YY; Chou MC; Lee H; Cheng YW Mol Vis; 2010 Apr; 16():623-9. PubMed ID: 20700368 [TBL] [Abstract][Full Text] [Related]
17. The effects of diet on DNA bulky adduct levels are strongly modified by GSTM1 genotype: a study on 634 subjects. Palli D; Masala G; Peluso M; Gaspari L; Krogh V; Munnia A; Panico S; Saieva C; Tumino R; Vineis P; Garte S Carcinogenesis; 2004 Apr; 25(4):577-84. PubMed ID: 14656945 [TBL] [Abstract][Full Text] [Related]
18. Genetic cancer susceptibility and DNA adducts: studies in smokers, tobacco chewers, and coke oven workers. Bartsch H; Rojas M; Nair U; Nair J; Alexandrov K Cancer Detect Prev; 1999; 23(6):445-53. PubMed ID: 10571654 [TBL] [Abstract][Full Text] [Related]
19. Hemoglobin adducts and sister chromatid exchanges in hospital workers exposed to ethylene oxide: effects of glutathione S-transferase T1 and M1 genotypes. Yong LC; Schulte PA; Wiencke JK; Boeniger MF; Connally LB; Walker JT; Whelan EA; Ward EM Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):539-50. PubMed ID: 11352866 [TBL] [Abstract][Full Text] [Related]
20. Sensitivity to DNA damage induced by benzo(a)pyrene diol epoxide and risk of lung cancer: a case-control analysis. Li D; Firozi PF; Wang LE; Bosken CH; Spitz MR; Hong WK; Wei Q Cancer Res; 2001 Feb; 61(4):1445-50. PubMed ID: 11245449 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]